YU19494A - Derivati cefalosporina - Google Patents

Derivati cefalosporina

Info

Publication number
YU19494A
YU19494A YU19494A YU19494A YU19494A YU 19494 A YU19494 A YU 19494A YU 19494 A YU19494 A YU 19494A YU 19494 A YU19494 A YU 19494A YU 19494 A YU19494 A YU 19494A
Authority
YU
Yugoslavia
Prior art keywords
lower alkyl
hydrogen
alkyl
cycloalkyl
alkenyl
Prior art date
Application number
YU19494A
Other languages
English (en)
Inventor
P. Angehrn
C.C. Wei
Original Assignee
F. Hoffman - La Roche Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffman - La Roche Ag. filed Critical F. Hoffman - La Roche Ag.
Publication of YU19494A publication Critical patent/YU19494A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

DERIVATI CEFALOSPORINA - Derivati cefaiosporina opšte formule u kojoj označavaju R1 acil-grupu izvedenu iz karboksilne kiseline, R2 vodonik, hidroksi, niži alkil-Qm, cikioalkil, niži alkoksi, niži alkenil, cikloalkenil, niži alkinil, aralkil-Qm, aril-Qm, ariloksi, aralkoksi ili heterociklicni prsten, pri cemu su niži alkil, cikioalkil, niži alkoksi, niži alkenil, cikloalkenil, niži alkinil, aralkil, aril, ariloksi, aralkoksi i heterociklični prsten nesupstituisani ili supstituisani najmanje jednom grupom odabranom iz grupe karboksi, amino, nitro, cijan, niži alkil, niži aikoksi, hidroksi, halogen, -CONR4R5, -N(R5)COOR9, RECO-, R5OCO- ili R5COO- gde R4 označava vodonik, niži alkil, ili cikioalkil, R5 je vodonik ili niži alkil, F!s je vodonik, niži alkil, niži alkenil ili grupa koja štiti karboksilnu kiselinu,Q -CO- ili -S02-m O ili 1, n O, 1 ili 2,kao i njihovi lako hidrolizujući esstri, farmaceutski prihvatljive soli pomenutih jedinjenja i hidrati jedinjenja formule I i njihovih estara i soli. Produkti su antibakterijski aktivni.
YU19494A 1993-04-16 1994-04-14 Derivati cefalosporina YU19494A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4868893A 1993-04-16 1993-04-16

Publications (1)

Publication Number Publication Date
YU19494A true YU19494A (sh) 1998-05-15

Family

ID=21955891

Family Applications (1)

Application Number Title Priority Date Filing Date
YU19494A YU19494A (sh) 1993-04-16 1994-04-14 Derivati cefalosporina

Country Status (7)

Country Link
US (1) US5523400A (sh)
KR (1) KR100309516B1 (sh)
EC (1) ECSP941068A (sh)
RO (1) RO114965B1 (sh)
TN (1) TNSN94030A1 (sh)
UY (1) UY23757A1 (sh)
YU (1) YU19494A (sh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1176641A (zh) * 1995-02-27 1998-03-18 弗·哈夫曼-拉罗切有限公司 3－吡咯烷亚基－2－酮－头孢菌素衍生物
CZ251896A3 (en) * 1995-09-12 1997-04-16 Hoffmann Ka Roche Ag F Cephalosporin derivatives
US5811419A (en) * 1996-01-16 1998-09-22 Hoffmann-La Roche Inc. Isooxacephem-derivatives
US5883247A (en) * 1996-06-10 1999-03-16 Hoffmann-La Roche Inc. Preparation of cephem and isooxacephem derivatives
TW446707B (en) * 1996-10-22 2001-07-21 Hoffmann La Roche Cephalosporin pyridinium derivatives
DK0841339T3 (da) 1996-11-06 2007-07-02 Basilea Pharmaceutica Ag Vinylpyrrolidinon-cephalosporinderivater
TW415949B (en) * 1996-12-19 2000-12-21 Hoffmann La Roche Vinyl pyrrolidine cephalosporin derivatives with basic substituents
US6114541A (en) * 1997-03-10 2000-09-05 Hoffmann-La Roche Inc. Method for the preparation of α-Bromo-Lactam derivatives
EP1090013A1 (en) * 1998-06-22 2001-04-11 F. Hoffmann-La Roche Ag Propenyl cephalosporin derivatives
EP1067131B1 (en) 1999-07-05 2007-08-15 Basilea Pharmaceutica AG New process for the manufacture of cephalosporin derivatives
AU2003294161A1 (en) * 2003-03-20 2004-10-11 Orchid Chemicals And Pharmaceuticals Ltd An improved process for the preparation of cefoxitin
US7105659B2 (en) * 2003-06-02 2006-09-12 Aurobind - Pharma Ltd. Process for preparing cefdinir
US20090214600A1 (en) * 2008-02-25 2009-08-27 Debrouse Daniel R Methods and compositions for gastric resistant oral formulations for intestinal delivery
MX352760B (es) 2011-09-09 2017-12-07 Merck Sharp & Dohme Corp Star Metodos para tratar infecciones intrapulmonares.
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
MX2020004205A (es) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN105418641B (zh) * 2015-12-30 2018-08-10 广东金城金素制药有限公司 一种原研制品质头孢曲松钠及其药物制剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496562A (en) * 1977-03-14 1985-01-29 Fujisawa Pharmaceutical Co., Ltd. 7-Substituted-3-cephem-4-carboxylic acid esters
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
IL84128A (en) * 1986-10-13 1992-12-01 Eisai Co Ltd 3-propenylcephem derivatives, their preparation and pharmaceutical compositions containing them
US5171854A (en) * 1987-05-26 1992-12-15 Bayer Aktiengesellschaft Substituted vinylcephalosporins
GB8821797D0 (en) * 1988-09-16 1988-10-19 Beecham Group Plc Novel compounds
PT620225E (pt) * 1993-04-16 2003-03-31 Basilea Pharmaceutica Ag Derivados de cefalosporina

Also Published As

Publication number Publication date
RO114965B1 (ro) 1999-09-30
TNSN94030A1 (fr) 1995-04-25
ECSP941068A (es) 1994-11-16
KR100309516B1 (ko) 2006-05-25
US5523400A (en) 1996-06-04
UY23757A1 (es) 1994-10-03

Similar Documents

Publication Publication Date Title
YU19494A (sh) Derivati cefalosporina
ES2185634T3 (es) Derivados de cefalosporina.
ES514947A0 (es) "un procedimiento de preparacion de derivados de bencimidazol".
ES8704955A1 (es) Un proceso para la produccion de un compuesto de cefalospo- rina
TW349098B (en) Naphthalene derivatives, process for the preparation thereof, and intermediates therefor
MX9604398A (es) Derivados de sulfonamida.
IL113778A (en) Condensed-indan derivatives pharmaceutical compositions containing the same and methods for the preparation thereof
ATE9474T1 (de) Cephalosporinverbindungen und ihre herstellung.
TW249804B (sh)
ATE234818T1 (de) Chinolinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ES2132245T3 (es) Derivados de 1-azaadamantano como agonistas o antagonistas de 5-ht.
GB1492573A (en) 9-substituted-pyrido(1,2-a)pyrimidines
ES8500223A1 (es) Un metodo de preparacion de derivados de oximas de halogenobenzofenonas.
JPS57163386A (en) Cephalosporin derivative and its production